FDA Approved: DEFINITY — Supplemental Application (Lantheus Medical Imaging, Inc.)

View source ↗

Summary

FDA approved a supplemental application for DEFINITY (perflutren) submitted by Lantheus Medical Imaging, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Heart Failure
• Ischemic Heart Disease

Drugs mentioned

• DEFINITY (perflutren lipid microspheres)

Snippet

SUPPL AP for DEFINITY (PERFLUTREN)